Clinical Trials Logo

Oropharyngeal Candidiasis clinical trials

View clinical trials related to Oropharyngeal Candidiasis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00608335 Completed - Candidemia Clinical Trials

Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug

Start date: October 14, 2007
Phase: Phase 1
Study type: Interventional

Children with fungal infections will be divided into two groups by weight. Children weighing < 25 kg will receive a higher dose of study medication (per kg body weight) for 10 to 14 days than children weighing > 25 kg.

NCT ID: NCT00607763 Completed - Candidemia Clinical Trials

Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug

Start date: October 2007
Phase: Phase 1
Study type: Interventional

Infants and toddlers with fungal infections will receive 10 to 14 days of treatment with an antifungal drug. Safety and drug blood levels will be assessed

NCT ID: NCT00553137 Completed - Clinical trials for Oropharyngeal Candidiasis

Single Dose Versus Two Weeks Course of Fluconazole in the Treatment of Oropharyngeal Candidiasis in HIV Infected Individuals in Tanzania

SDVS2WK
Start date: November 2006
Phase: Phase 4
Study type: Interventional

A prospective randomized double blinded placebo controlled comparative trial will be performed at HIV clinic of the Muhimbili National Hospital/MUCHS where 220 HIV positive patients presenting with oropharyngeal candidiasis (OPC) on antiretroviral (ARVs) treatment or not will be included. The aim of this study is to compare the efficacy and safety of single dose fluconazole (750mg) and two weeks course of fluconazole (150mg once daily)in the treatment of OPC in HIV positive patients. It is hypothesised that the two regimens are equally effective in the treatment of OPC.